These questions are intended to determine the hematological status of the recipient post-infusion. Testing may be performed multiple times within the reporting period; however, report the most recent (closest to the contact date) laboratory values.
Question 17-20: Select all known hematologic labs (check all that apply)
Indicate any known hematologic labs completed within the current reporting period.
- Erythroferrone (ERFE): The main erythroid regulator of hepcidin, the homeostatic hormone controlling plasma iron levels and total body iron
- Growth/differentiation factor (GDF15): Member of the transforming growth factor-β superfamily, participates in processes associated with myeloma development and its end-organ complications.
- Nucleated RBC (erythroblast): Premature erythrocyte precursors that reside in the bone marrow of humans of all ages as an element of erythropoiesis.
If none of the listed labs were completed in the current reporting period, select None.
Section Updates:
| Question Number | Date of Change | Add/Remove/Modify | Description | Reasoning (If applicable) |
|---|---|---|---|---|
| . | . | . | . | . |
Last modified:
Sep 30, 2024
Need more help with this?
Don’t hesitate to contact us here.